Brick & Kyle, Associates Exact Sciences Corp Transaction History

Brick & Kyle, Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jun 13, 2019	SELL	$56.04 - $82.66 $223,599 - $329,813	-3,990 Reduced 52.85%	3,560 $224,000
Q1 2018 May 10, 2018	SELL	$39.82 - $57.53 $7,964 - $11,506	-200 Reduced 2.58%	7,550 $304,000
Q4 2017 Jan 24, 2018	SELL	$46.49 - $60.51 $11,622 - $15,127	-250 Reduced 3.13%	7,750 $407,000
Q3 2017 Nov 08, 2017	BUY	$37.05 - $47.12 $296,400 - $376,960	8,000	8,000 $377,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Brick & Kyle, Associates, based on Form 13F filings with the SEC.

Stay updated on Brick & Kyle, Associates with notifications on news.